This page shows the latest Caplyta news and features for those working in and with pharma, biotech and healthcare.
Intra-Cellular has argued that this differentiates Caplyta from existing schizophrenia drugs, maintaining that it provides additional benefits such as improved psychosocial functioning. ... The approval is an early Christmas present for Intra-Cellular,
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...